Toshiaki Tamaki Selected Research

Irinotecan (Camptosar)

3/2019

Irinotecan-induced neutropenia is reduced by oral alkalization drugs: analysis using retrospective chart reviews and the spontaneous reporting database.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Toshiaki Tamaki Research Topics

Disease

13	Cardiovascular Diseases (Cardiovascular Disease) 03/2020 - 05/2002
11	Hypoxia (Hypoxemia) 01/2020 - 05/2009
9	Atherosclerosis 03/2020 - 01/2003
9	Hypertension (High Blood Pressure) 08/2015 - 08/2003
7	Inflammation (Inflammations) 10/2023 - 02/2011
6	Diabetic Nephropathies (Diabetic Nephropathy) 10/2023 - 07/2002
6	Neoplasms (Cancer) 09/2021 - 06/2005
6	Hypertrophy 01/2019 - 05/2002
6	Ischemia 11/2015 - 03/2002
6	Vascular Remodeling 01/2014 - 08/2004
5	Proteinuria 10/2023 - 03/2006
5	Obesity 01/2020 - 11/2011
4	Albuminuria 10/2023 - 01/2014
4	Fibrosis (Cirrhosis) 08/2023 - 08/2005
4	Type 2 Diabetes Mellitus (MODY) 08/2023 - 11/2011
4	Anemia 01/2020 - 01/2017
4	Glomerulonephritis 02/2010 - 07/2002
3	Aortic Aneurysm (Aneurysm, Aortic) 03/2020 - 11/2016
2	Insulin Resistance 01/2020 - 08/2005
2	Drug-Related Side Effects and Adverse Reactions 03/2019 - 01/2019
2	Iron Overload 01/2019 - 01/2019
2	Atrophy 01/2019 - 05/2016
2	Chronic Renal Insufficiency 01/2018 - 08/2009
2	Necrosis 01/2017 - 01/2012
2	Arteriosclerosis 01/2011 - 02/2010
2	Reperfusion Injury 01/2005 - 03/2002
1	Non-alcoholic Fatty Liver Disease 08/2023
1	Diabetes Mellitus 12/2021
1	Acute Kidney Injury (Acute Renal Failure) 01/2021

Drug/Important Bio-Agent (IBA)

13	Angiotensin IIIBA 01/2018 - 05/2002
11	IronIBA 01/2020 - 01/2012
6	Glucose (Dextrose)FDA LinkGeneric 10/2023 - 11/2011
6	NG-Nitroarginine Methyl Ester (L-NAME)IBA 02/2010 - 08/2003
5	Messenger RNA (mRNA)IBA 01/2018 - 02/2011
5	NitritesIBA 02/2010 - 12/2004
5	MitogensIBA 02/2010 - 05/2002
4	Superoxides (Superoxide)IBA 01/2019 - 07/2010
4	nitrosonifedipineIBA 01/2018 - 01/2013
4	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2017 - 03/2002
4	Proteins (Proteins, Gene)FDA Link 01/2015 - 05/2002
4	CytokinesIBA 01/2012 - 03/2003
4	QuercetinIBA 01/2011 - 05/2002
4	FlavonoidsIBA 01/2011 - 05/2002
3	Biomarkers (Surrogate Marker)IBA 10/2023 - 12/2021
3	Heparin Cofactor IIIBA 08/2023 - 10/2012
3	Transcription Factors (Transcription Factor)IBA 01/2020 - 05/2009
3	AminopropionitrileIBA 01/2019 - 11/2016
3	Dietary IronIBA 01/2019 - 04/2013
3	AntioxidantsIBA 01/2018 - 08/2004
3	CollagenIBA 01/2014 - 08/2005
3	Insulin (Novolin)FDA Link 11/2011 - 08/2005
3	glycosylated-nitric oxide complex hemoglobin AIBA 05/2006 - 08/2003
3	Phosphotransferases (Kinase)IBA 08/2004 - 05/2002
2	Thrombin FDA Link 08/2023 - 12/2021
2	Antineoplastic Agents (Antineoplastics)IBA 09/2021 - 07/2010
2	Cisplatin (Platino)FDA LinkGeneric 09/2021 - 01/2021
2	Oxygen (Dioxygen)IBA 01/2020 - 01/2015
2	UbiquitinIBA 01/2019 - 05/2016
2	Ligases (Synthetase)IBA 01/2019 - 05/2016
2	Chelating AgentsIBA 01/2019 - 01/2014
2	Hydroxyl RadicalIBA 01/2019 - 02/2004
2	Ferritins (Ferritin)IBA 01/2018 - 08/2015
2	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2015 - 01/2014
2	Free RadicalsIBA 10/2014 - 01/2011
2	Deferoxamine (Desferal)FDA LinkGeneric 01/2014 - 01/2012
2	Hypoxia-Inducible Factor 1IBA 04/2013 - 02/2010
2	p38 Mitogen-Activated Protein KinasesIBA 02/2011 - 02/2004
2	Antihypertensive Agents (Antihypertensives)IBA 01/2011 - 02/2009
2	AntigensIBA 01/2011 - 02/2010
2	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 01/2011 - 05/2002
2	AndrogensIBA 07/2010 - 08/2005
2	Androgen Receptors (Androgen Receptor)IBA 07/2010 - 08/2005
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 02/2010 - 01/2005
2	Hemoglobins (Hemoglobin)IBA 02/2010 - 11/2008
2	NitratesIBA 02/2010 - 12/2004
2	dinitrosyl iron complexIBA 02/2010 - 11/2008
2	olmesartanIBA 02/2010 - 05/2006
2	N- (2- chloro- 5- methoxyphenyl)- 6- methoxy- 7- ((1- methyl- 4- piperidinyl) methoxy) 4-quinazolinamineIBA 09/2006 - 06/2005
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2006 - 06/2005
2	src-Family KinasesIBA 09/2006 - 06/2005
2	anilinoquinazolineIBA 09/2006 - 06/2005
2	Probucol (Lorelco)FDA Link 03/2006 - 08/2004
2	AldosteroneIBA 10/2005 - 04/2005
2	ebselenIBA 02/2004 - 01/2004
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2004 - 03/2003
1	Sodium-Glucose Transporter 2 InhibitorsIBA 10/2023
1	AngiotensinsIBA 10/2023
1	SodiumIBA 10/2023
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 10/2023
1	ReninIBA 10/2023
1	Proteinase-Activated ReceptorsIBA 08/2023
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 08/2023
1	AlbuminsIBA 12/2021
1	CreatinineIBA 12/2021
1	Fatty Acid-Binding ProteinsIBA 12/2021
1	Diphenhydramine (Benadryl)FDA LinkGeneric 01/2021
1	Protein Kinases (Protein Kinase)IBA 03/2020

Therapy/Procedure

3	Oral Administration 02/2010 - 08/2003
2	Lasers (Laser) 11/2015 - 10/2012
1	Aftercare (After-Treatment) 10/2023